Molecular evidence-based use of bone resorption-targeted therapy in prostate cancer patients at high risk for bone involvement. - Karamanolakis,D.; Bogdanos,J.; Sourla,A.; Milathianakis,C.; Tsintavis,A.; Lembessis,P.; Tenta,R.; Tiblalexi,D.; Koutsilieris,M. (Mol Med, 2002)